• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MedSun: E-mail This Item To a Friend

  • Print
  • Share
  • E-mail
-

E-mail This Item To a Friend

Sending the item "Early Communication About an Ongoing Safety Review of Tumor Necrosis Factor (TNF) Blockers (marketed as Remicade, Enbrel, Humira, and Cimzia)" to a friend.

NOTE: This item will be sent from the e-mail address medsun@cdrh.fda.gov. Your email address will be noted in the body of the message. Some mailing lists restrict submissions to previously cleared email addresses. If you want to forward this item to a mailing list, you may want to first send the item to yourself and then forward the message from your email account.

(Optional)
 

Or, you may resume reading the newsletter.

Updated August 31, 2014

Return to MedSun: Medical Product Safety Network

-
-